Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)- 4-(3,4-dichlorohphenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof

Details for Australian Patent Application No. 2010247735 (hide)

Owner Bristol-Myers Squibb Company

Inventors Wei, Chenkou; Rosso, Victor W.; Gao, Qi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010247735

PCT Pub. Number WO2010/132487

Priority 61/177,486 12.05.09 US

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

A01N 43/42 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/47 (2006.01) - Quinolines

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/132487 Priority application(s): WO2010/132487

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247748-Use of buoyant gases for the simulation of real fire sources

2010247734-Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers